Finder may earn compensation from partners, but editorial opinions are our own. Advertiser Disclosure
INVO Bioscience Inc is a medical devices business based in the US. INVO Bioscience shares (INVO) are listed on the NASDAQ and all prices are listed in US Dollars. INVO Bioscience employs 10 staff and has a trailing 12-month revenue of around 0.00.
Our top pick for
Beginners
Our top pick for
Guided Investing
Our top pick for
Large Accounts
| Latest market close | $3.44 |
|---|---|
| 52-week range | $2.95 - $6.32 |
| 50-day moving average | $3.59 |
| 200-day moving average | $4.06 |
| Wall St. target price | $5.63 |
| PE ratio | N/A |
| Dividend yield | N/A (0%) |
| Earnings per share (TTM) | $-1.22 |
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $3.44 from 2021-10-25
| 1 week (2021-10-19) | -12.69% |
|---|---|
| 1 month (2021-09-27) | 2.69% |
| 3 months (2021-07-27) | -15.69% |
| 6 months (2021-04-27) | -22.87% |
| 1 year (2020-10-26) | -12.91% |
|---|---|
| 2 years (2019-10-25) | 1,086.21% |
| 3 years (2018-10-26) | 770.89% |
| 5 years (2016-10-26) | 760.00% |
| Revenue TTM | $1.4 million |
|---|---|
| Gross profit TTM | $958,251 |
| Return on assets TTM | -66.42% |
| Return on equity TTM | -2591.68% |
| Profit margin | 0% |
| Book value | $0.42 |
| Market capitalisation | $43.9 million |
TTM: trailing 12 months
There are currently 109,431 INVO Bioscience shares held short by investors – that's known as INVO Bioscience's "short interest". This figure is 17.2% down from 132,187 last month.
There are a few different ways that this level of interest in shorting INVO Bioscience shares can be evaluated.
INVO Bioscience's "short interest ratio" (SIR) is the quantity of INVO Bioscience shares currently shorted divided by the average quantity of INVO Bioscience shares traded daily (recently around 38262.587412587). INVO Bioscience's SIR currently stands at 2.86. In other words for every 100,000 INVO Bioscience shares traded daily on the market, roughly 2860 shares are currently held short.
To gain some more context, you can compare INVO Bioscience's short interest ratio against those of similar companies.
However INVO Bioscience's short interest can also be evaluated against the total number of INVO Bioscience shares, or, against the total number of tradable INVO Bioscience shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case INVO Bioscience's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 INVO Bioscience shares in existence, roughly 10 shares are currently held short) or 0.0108% of the tradable shares (for every 100,000 tradable INVO Bioscience shares, roughly 11 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against INVO Bioscience.
Find out more about how you can short INVO Bioscience stock.
We're not expecting INVO Bioscience to pay a dividend over the next 12 months.
You may also wish to consider:
INVO Bioscience's shares were split on a 5:8 basis on 8 November 2020. So if you had owned 8 shares the day before before the split, the next day you'd have owned 5 shares. This wouldn't directly have changed the overall worth of your INVO Bioscience shares – just the quantity. However, indirectly, the new 60% higher share price could have impacted the market appetite for INVO Bioscience shares which in turn could have impacted INVO Bioscience's share price.
Over the last 12 months, INVO Bioscience's shares have ranged in value from as little as $2.95 up to $6.32. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while INVO Bioscience's is -1.0333. This would suggest that INVO Bioscience's shares have been inversely-correlated to the average (for this exchange) – so when the broader market trended up or down, INVO Bioscience has bucked the trend.
To put INVO Bioscience's beta into context you can compare it against those of similar companies.
INVO Bioscience, Inc. , a medical device company, provides assisted reproductive technology solutions worldwide. It offers INVOcell, a patented intravaginal culture system used for the natural in vivo incubation of eggs and sperm during fertilization and early embryo development. The company was founded in 2007 and is based in Sarasota, Massachusetts. .
Steps to owning and managing ProShares Bitcoin Strategy ETF units.
Everything we know about the The Real Good Food Company IPO, plus information on how to buy in.
Everything we know about the Lulu’s Fashion Lounge Holdings IPO, plus information on how to buy in.
Everything we know about the Allarity Therapeutics IPO, plus information on how to buy in.
Everything we know about the Jupiter Neurosciences IPO, plus information on how to buy in.
Everything we know about the Mainz Biomed IPO, plus information on how to buy in.
Everything we know about the Progressive Care IPO, plus information on how to buy in.
Everything we know about the Desert Peak Minerals IPO, plus information on how to buy in.
Everything we know about the Vaxxinity IPO, plus information on how to buy in.
Everything we know about the Entrada Therapeutics IPO, plus information on how to buy in.